Advertisement

Acute Hospital Outcomes for Renal Transplantation in Patients With Moderate or Severe Congenital Heart Disease

Published:November 06, 2022DOI:https://doi.org/10.1016/j.amjcard.2022.10.034
      Children and adults with congenital heart disease (CHD) are increasingly recognized to be at risk for acute and chronic renal injury. Some of these may progress to the need for renal transplantation. We hypothesized that patients with underlying moderate or severe CHD who undergo renal transplantation will have worse acute hospital outcomes. Using a national administrative database, we queried for admissions aged 0 to 50 years with moderate or severe CHD and renal transplantation and compared these to admissions without CHD. There were 56 admissions for renal transplantation in the CHD group (0.04%) and 26,285 admissions in the group without CHD (0.21%, p<0.001). The CHD group were younger, had a higher proportion of Whites, longer length of stay, higher complication rates, higher in-hospital mortality, and higher costs. In conclusion, although renal transplantation is still relatively uncommon in the CHD population, there is an increasing recognition of severe chronic renal disease in the setting of CHD, making it important to understand the potential implications of these findings.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Marelli AJ
        • Ionescu-Ittu R
        • Mackie AS
        • Guo L
        • Dendukuri N
        • Kaouache M.
        Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010.
        Circulation. 2014; 130: 749-756
        • Diller GP
        • Arvanitaki A
        • Opotowsky AR
        • Jenkins K
        • Moons P
        • Kempny A
        • Tandon A
        • Redington A
        • Khairy P
        • Mital S
        • Gatzoulis MΑ
        • Li Y
        • Marelli A.
        Lifespan perspective on congenital heart disease research: JACC state-of-the-art review.
        J Am Coll Cardiol. 2021; 77: 2219-2235
        • Lui GK
        • Saidi A
        • Bhatt AB
        • Burchill LJ
        • Deen JF
        • Earing MG
        • Gewitz M
        • Ginns J
        • Kay JD
        • Kim YY
        • Kovacs AH
        • Krieger EV
        • Wu FM
        • Yoo SJ
        American Heart Association Adult Congenital Heart Disease Committee of the Council on Clinical Cardiology and Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; and Council on Quality of Care and Outcomes Research. Diagnosis and management of noncardiac complications in adults with congenital heart disease: a scientific statement From the American Heart Association.
        Circulation. 2017; 136: e348-e392
        • Hongsawong N
        • Khamdee P
        • Silvilairat S
        • Chartapisak W.
        Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease.
        Pediatr Nephrol. 2018; 33: 493-501
        • Uber AM
        • Montez-Rath ME
        • Kwiatkowski DM
        • Krawczeski CD
        • Sutherland SM.
        Nephrotoxin exposure and acute kidney injury in critically ill children undergoing congenital cardiac surgery.
        Pediatr Nephrol. 2018; 33: 2193-2199
        • Gist KM
        • Kwiatkowski DM
        • Cooper DS.
        Acute kidney injury in congenital heart disease.
        Curr Opin Cardiol. 2018; 33: 101-107
        • Gaeta SA
        • Ward C
        • Krasuski RA.
        Extra-cardiac manifestations of adult congenital heart disease.
        Trends Cardiovasc Med. 2016; 26: 627-636
        • Filler G
        • Melk A
        • Marks SD.
        Practice recommendations for the monitoring of renal function in pediatric non-renal organ transplant recipients.
        Pediatr Transplant. 2016; 20: 352-363
        • McAdams-DeMarco MA
        • King EA
        • Luo X
        • Haugen C
        • DiBrito S
        • Shaffer A
        • Kucirka LM
        • Desai NM
        • Dagher NN
        • Lonze BE
        • Montgomery RA
        • Walston J
        • Segev DL.
        Frailty, length of stay, and mortality in kidney transplant recipients: a national registry and prospective cohort study.
        Ann Surg. 2017; 266: 1084-1090
        • Stout KK
        • Daniels CJ
        • Aboulhosn JA
        • Bozkurt B
        • Broberg CS
        • Colman JM
        • Crumb SR
        • Dearani JA
        • Fuller S
        • Gurvitz M
        • Khairy P
        • Landzberg MJ
        • Saidi A
        • Valente AM
        • Van Hare GF.
        2018 AHA/ACC guideline for the management of adults With congenital heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines.
        Circulation. 2019; 139: e698-e800
        • Hoffman JI
        • Kaplan S.
        The incidence of congenital heart disease.
        J Am Coll Cardiol. 2002; 39: 1890-1900
        • Madsen NL
        • Goldstein SL
        • Frøslev T
        • Christiansen CF
        • Olsen M.
        Cardiac surgery in patients with congenital heart disease is associated with acute kidney injury and the risk of chronic kidney disease.
        Kidney Int. 2017; 92: 751-756
        • Parikh CR
        • Greenberg JH
        • McArthur E
        • Thiessen-Philbrook H
        • Everett AD
        • Wald R
        • Zappitelli M
        • Chanchlani R
        • Garg AX.
        Incidence of ESKD and mortality among children with congenital heart disease after cardiac surgery.
        Clin J Am Soc Nephrol. 2019; 14: 1450-1457
        • Dimopoulos K
        • Diller GP
        • Koltsida E
        • Pijuan-Domenech A
        • Papadopoulou SA
        • Babu-Narayan SV
        • Salukhe TV
        • Piepoli MF
        • Poole-Wilson PA
        • Best N
        • Francis DP
        • Gatzoulis MA.
        Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease.
        Circulation. 2008; 117: 2320-2328
        • Holt T
        • Filler G.
        Is it time for a multi-specialty approach to cardio-renal dysfunction in children with cyanotic congenital heart disease?.
        Pediatr Nephrol. 2018; 33: 359-360
        • R Patel S
        • M Kwiatkowski D
        • Adin-Cristian rei
        • Devareddy A
        • Shi H
        • D Krawczeski C
        • Ebert N
        • J Deal B
        • B Langman C
        • S Marino B
        Prevalence and risk factors associated with renal dysfunction in patients with single ventricle congenital heart disease after Fontan palliation.
        Congenit Heart Dis. 2020; 15: 181-195
        • San Agustin JT
        • Klena N
        • Granath K
        • Panigrahy A
        • Stewart E
        • Devine W
        • Strittmatter L
        • Jonassen JA
        • Liu X
        • Lo CW
        • Pazour GJ.
        Genetic link between renal birth defects and congenital heart disease.
        Nat Commun. 2016; 7: 11103
        • Nafar M
        • Sahraei Z
        • Salamzadeh J
        • Samavat S
        • Vaziri ND.
        Oxidative stress in kidney transplantation: causes, consequences, and potential treatment.
        Iran J Kidney Dis. 2011; 5: 357-372
        • Hwang HV
        • Sandeep N
        • Paige SL
        • Ranjbarvaziri S
        • Hu DQ
        • Zhao M
        • Lan IS
        • Coronado M
        • Kooiker KB
        • Wu SM
        • Fajardo G
        • Bernstein D
        • Reddy S.
        4HNE impairs myocardial bioenergetics in congenital heart disease-induced right ventricular failure.
        Circulation. 2020; 142: 1667-1683